Liu Xuebing, Wu Xiaoheng, Tang Jianhua, Zhang Lin, Jia Xu
Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan 610050, People's Republic of China.
Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Infect Drug Resist. 2020 Sep 16;13:3195-3208. doi: 10.2147/IDR.S264391. eCollection 2020.
Data visualization software were used to display and analyze the research status, hotspot and development trend of the antibiotic-resistance of objectively and comprehensively, so as to provide guidance and reference for the research of the antibiotic-resistant .
The data of relevant publications on antibiotic-resistant from 1991 to 2019 were retrieved from Web of Science (WOS) Core database. VOSviewer and CiteSpace software were used to conduct co-citation visualization network rendering and cluster analysis on the publications' years, authors, countries, institutions, keywords and citations.
A total of 3915 valid records on the study of antibiotic-resistant were retrieved. The number of relevant publications was increasing year after year. The United States is the most influential country in the field, which works closely with other countries and publishes most of the papers. University of Sydney is the leading institution in this area. Bonomo Robert A publishes most of the papers. There are the highest number of publications in the research areas of antimicrobial agents and chemotherapy. "Nucleotide sequence" and "outbreak" were once the hotspots in this field, but recently "bacteriophage", "biofilm" and "colistin resistance" have become the research hotspots.
Since 1991, the number of publications on antibiotic-resistant has grown rapidly, and various countries and institutions have paid close attention to the problem of antibiotic resistance. Countries, institutions and researchers, which have strong influential power, collaborate with each other closely. The future research direction of antibiotic-resistant should lie in the further breakthrough of antibacterial peptides, bacteriophage therapy, CRISPR system and various combined therapies.
运用数据可视化软件客观、全面地展示和分析抗生素耐药性的研究现状、热点及发展趋势,为抗生素耐药性研究提供指导与参考。
从Web of Science(WOS)核心数据库中检索1991年至2019年有关抗生素耐药性的相关出版物数据。使用VOSviewer和CiteSpace软件对出版物的年份、作者、国家、机构、关键词和被引频次进行共被引可视化网络绘制和聚类分析。
共检索到3915条关于抗生素耐药性研究的有效记录。相关出版物数量逐年增加。美国是该领域最具影响力的国家,与其他国家合作紧密且发表论文最多。悉尼大学是该领域的领先机构。博诺莫·罗伯特·A发表的论文最多。抗菌药物与化疗研究领域的出版物数量最多。“核苷酸序列”和“暴发”曾是该领域的热点,但最近“噬菌体”“生物膜”和“黏菌素耐药性”已成为研究热点。
自1991年以来,抗生素耐药性相关出版物数量增长迅速,各国和各机构都密切关注抗生素耐药性问题。具有强大影响力的国家、机构和研究人员之间相互密切合作。抗生素耐药性未来的研究方向应在于抗菌肽、噬菌体疗法、CRISPR系统及各种联合疗法的进一步突破。